References
- Asaga S, Kuo C, Nguyen T, et al (2011). Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem, 57, 84-91. https://doi.org/10.1373/clinchem.2010.151845
- Asangani IA, Rasheed SA, Nikolova DA, et al (2008). MicroRNA-21 (miR-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-36. https://doi.org/10.1038/sj.onc.1210856
- Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasions in cancer cells. EMBO Rep, 9, 582-9. https://doi.org/10.1038/embor.2008.74
-
Cai WY, Wei TZ, Wu QC, et al (2013). Wnt/
${\beta}$ -catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci, 126, 2877-89. https://doi.org/10.1242/jcs.123810 -
Cai JC, Guan HY, Fang LS, et al (2013). MicroRNA-374a activates Wnt/
${\beta}$ -catenin signaling to promote breast cancer metastasis. J Clin Invest, 123, 566-76. - Chen J, Wang L, Matyunina LV, et al (2011). Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol. Oncol, 121, 200-5. https://doi.org/10.1016/j.ygyno.2010.12.339
- Frankel LB, Christoffersen NR, Jacobsen A, et al (2008). Programmed cell death 4 (PDCD) is an important functional target of the microRNA miR-21 in breast cancer cells. Biol Chem, 283, 1026-33. https://doi.org/10.1074/jbc.M707224200
- Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601. https://doi.org/10.1038/ncb1722
- Hashimi ST, Fulcher JA, Chang MH, et al (2009). MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood, 114, 404-14. https://doi.org/10.1182/blood-2008-09-179150
- Hatzis P, van der Flier LG, van Driel MA, et al (2008). Genome-Wide Pattern of TCF7L2/TCF4 Chromatin Occupancy in Colorectal Cancer Cells. Mol Cell Biol, 28, 2732-44. https://doi.org/10.1128/MCB.02175-07
- Heo I, Joo C, Cho J, et al (2008). Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell, 32, 276-84. https://doi.org/10.1016/j.molcel.2008.09.014
- Huang GL, Guo GL, Zhang XH (2008). The research progress of miRNAs in breast cancer. Chinese Journal of breast diseases (electronic version), 2, 301-7.
- Huang K, Zhang JX, Han L, et al (2010). MicroRNA roles in beta-catenin pathway. Mol Cancer, 9, 252. https://doi.org/10.1186/1476-4598-9-252
- Hutvagner G, Zamore PD (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-60. https://doi.org/10.1126/science.1073827
- Indik S, Guzburg WH, Salmons B, et al (2005). Mouse mammary tumor virus infects human cells. Cancer Res, 65, 6651-9. https://doi.org/10.1158/0008-5472.CAN-04-2609
- Kong D, Li Y, Wang Z, et al (2009). miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-21. https://doi.org/10.1002/stem.101
- Korpal M, Lee ES, Hu G, et al (2008). The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem, 283, 14910-4. https://doi.org/10.1074/jbc.C800074200
- Kruger JA, Kaplan CD, Luo Y, et al (2006). Characterization of stem cell-like cancer cells in immune-competent mice. Blood, 108, 3906-12. https://doi.org/10.1182/blood-2006-05-024687
- Ladeiro, Y, Couchy, G, Balabaud, C, et al (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-63. https://doi.org/10.1002/hep.22256
- Lai EC (2002). MicroRNAs are complementary to 3'UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet, 30, 363-4. https://doi.org/10.1038/ng865
- Lee RC, Feinbaum RL, Ambros V, et al (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54. https://doi.org/10.1016/0092-8674(93)90529-Y
- Liu B, Wang Y, Melana SM, et al (2001). Identification of a proviral structure n human breast cancer. Clinic Cancer Res, 61, 1754-9.
- Luo T, Wu XT, Zhang MM, et al (2006). Study of mouse mammary tumor virus-like gene sequences expressing in breast tumors of Chinese women. J Sichuan University (Medical Science Edition), 37, 844-6.
- Martello G, Zacchigna L, Inui M, et al (2007). MicroRNA control of Nodal signaling. Nature, 449, 183-8. https://doi.org/10.1038/nature06100
- Melana SM, Holland JF, Pogo BGT, (2001). Search for Mouse Mammary Tumor Virus-like env Sequences in Cancer and Normal Breast from the Same Individuals. Clinic Cancer Res, 7, 283-4.
- Mok MT, Lawson JS, Iacopetta BJ, et al (2008). Mouse mammary tumor virus-like env sequences in human breast cancer. Int J Cancer, 122, 2864-70. https://doi.org/10.1002/ijc.23372
- Newman MA, Thomson JM, Hammond SM, et al (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA, 14, 1539-49. https://doi.org/10.1261/rna.1155108
- Ono M, Yasunaga T, Miyata T, et al (1986). Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. Virol, 60, 589-98
- Park SM, Gaur AB, Lengyel E, et al (2008). The miR-200 family determies the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 22, 894-907. https://doi.org/10.1101/gad.1640608
- Parkin NT, Kitajewski J, Varmus HE, et al (1993). Activity of Wnt-1 as a transmembrane protein. Genes Dev, 7, 2181-93. https://doi.org/10.1101/gad.7.11.2181
- Pasquinelli AE, Reinhart BJ, Slack F, et al (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408, 86-9. https://doi.org/10.1038/35040556
- Patrawala L, Calhoun T, Schneider-Broussard R, et al (2005). Side Population Is Enriched in Tumorigenic, Stem-Like Cancer Cells, whereas ABCG2+ and ABCG2-Cancer Cells Are Similarly Tumorigenic. Cancer Res, 65, 6207-19. https://doi.org/10.1158/0008-5472.CAN-05-0592
- Piskounova E, Viswanathan SR, Janas M, et al (2008). Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem, 283, 21310-4. https://doi.org/10.1074/jbc.C800108200
- Reddy SD, Ohshiro K, Rayala SK, et al (2008). MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res, 68, 8195-200. https://doi.org/10.1158/0008-5472.CAN-08-2103
- Reinhart BJ, Slack FJ, Basson M, et al (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901-6. https://doi.org/10.1038/35002607
- Rybak A, Fuchs H, Smirnova L, et al (2008). A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol, 10, 987-93. https://doi.org/10.1038/ncb1759
- Si ML, Zhu S, Wu H, et al (2007). miR-21-mediated tumor growth. Oncogene, 26, 2799-803. https://doi.org/10.1038/sj.onc.1210083
- Stingl J, Eirew P, Ricketson I, et al (2006). Purification and unique properties of mammary epithelial stem cells. Nature, 439, 993-7.
-
Tepera SB, McCrea PD, Rosen JM, (2003). A
${\beta}$ -catenin survival signal is required for normal lobular development in the mammary gland. Cell Sci, 116, 1137-49. https://doi.org/10.1242/jcs.00334 - Theodorou V, Kimm MA, Boer M, et al (2007). MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet, 39, 759-69. https://doi.org/10.1038/ng2034
- Tryndyak VP, Beland FA, Pogribny IP (2010). E-cadherin transcriptional downregulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer, 126, 2575-83.
- Tsukamoto AS, Grosschedl R, Guzman RC, et al (1988). Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55, 619-25. https://doi.org/10.1016/0092-8674(88)90220-6
- Volinia S, Calin GA, Liu C G, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61. https://doi.org/10.1073/pnas.0510565103
- Wang Y, Holland JF, Bleiweiss IJ, et al (1995). Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res, 55, 5173-9.
- Wang Y, PelissOn I, Melana SM, et al (2001). MMTV-like env gene seguences in human breast cancer. Arch Virol, 146, 171-80. https://doi.org/10.1007/s007050170201
- Yan LX, Huang XF, Shao Q, et al (2008). MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 14, 2348-60. https://doi.org/10.1261/rna.1034808
- Yu F, Yao H, Zhu P, et al (2007). let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-23. https://doi.org/10.1016/j.cell.2007.10.054
- Zapata-Benavides P, Saavedra-Alonso S, Zamora-Avila D, et a1 (2007). Mouse mammary tumor virus-like gene sequences in breast cancer samples of Mexican women. Intervirology, 50, 402-7. https://doi.org/10.1159/000110652
- Zeng Y, Yi R, Cullen BR, (2003). MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA, 100, 9779-84. https://doi.org/10.1073/pnas.1630797100
- Zhu S, Si ML, Wu H, et a1 (2007). MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPMl). Biol Chem, 282, 14328-36. https://doi.org/10.1074/jbc.M611393200
Cited by
- Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5625
- Short hairpin RNA silencing of TGF-βRII and FZD-7 synergistically suppresses proliferation and metastasis of hepatocellular carcinoma cells vol.11, pp.3, 2016, https://doi.org/10.3892/ol.2016.4208